CA SB310

Establishes the Cancer Medication Recycling Act, effective until January 1, 2027, allowing collection and redistribution of unused cancer medications through registered practitioners and surplus medication intermediaries.

Requires participating practitioners to be licensed physicians board-certified in medical oncology or hematology, registered with a surplus medication collection and distribution intermediary, and to charge a fee not exceeding $300 for registration.

Restricts eligible medications to unopened, tamper-evident cancer drugs in original packaging; excludes controlled substances, opioids, compounded medications, injectable medications, and drugs with FDA Risk Evaluation and Mitigation Strategy requirements.

Provides immunity from criminal and civil liability for donors, practitioners, manufacturers, and intermediaries participating in the program, except in cases of gross negligence, recklessness, intentional conduct, or malpractice unrelated to medication quality.

Requires participating practitioners to maintain records for three years, establish distribution criteria, monitor FDA recalls, and ensure donated medications are stored and handled according to manufacturer specifications.